Your SlideShare is downloading. ×
0
To thin or not to thin?
Dr Sarah Wesley
Cairns 2013
64yo CABG x3
• On pump, LIMA to LAD and SVG to OM1 and Cx
• PMHx: hypertension and hypercholesterolaemia
• What antiplatel...
64yo CABG x3
• Aspirin at 6h if bleeding not an issue and daily
afterwards
• 75-150mg optimal dose
• Reduction in mortalit...
64yo CABG x3
• Are there any indications for dual (aspirin and
clopidogrel) antiplatelet therapy?
64yo CABG x3
• Dual therapy
• CABG post acute coronary syndrome
• Stent in situ not bypassed by graft
• Off-pump CABG
• No...
64yo CABG x3
• Clopidogrel acceptable alternative if allergic to
aspirin
• No data showing superior
• Aspirin remains drug...
64yo CABG x3
• He goes on to develop AF day 2
• 3 days later remains in rate controlled AF on
amiodarone
• Would you start...
64yo CABG x3
• iv heparin and warfarin if remains in AF for > 48h
• Aim INR 2-3
• Double the risk of stroke with no antico...
Questions ?
72yo tissue AVR
• EF 45% with moderate LVH
• Sinus rhythm
• No previous DVT/PE
• No post-operative complications
• What an...
72yo tissue AVR
• No risk factors for VTE disease -> aspirin alone
• Stroke rate of 0.2% for AVR in sinus
Clopidogrel Aspi...
72yo tissue AVR
• Risk factors for VTE disease
• AF, EF< 30-35%, hypercoagulable or previous VTE
• Warfarin with INR 2-3
C...
54yo Mechanical AVR
• What if he was 54 and his original operation was a
mechanical AVR?
• Normal coronary arteries
• No r...
54yo Mechanical AVR
• Warfarin and iv heparin
• Iv heparin continues till INR therapeutic for 2 days
• Intensity of warfar...
Mechanical AVR
• Warfarin alone or combination warfarin and anti-
platelets?
• Balance of thrombosis risk vs bleeding
Mechanical AVR
• Add aspirin to warfarin if risk factors for
cardiovascular disease, stents, previous PE, high risk
valve
...
63yo with mechanical MVR
• Second generation valve inserted
• Past history of Atrial Fibrillation
• EF 40%
• What anticoag...
MV repair or tissue MV
• What if she’d had a mitral valve repair or tissue
valve rather than mechanical valve replacement ...
MV repair or tissue MV
• 3 months warfarin or antiplatelets
• No evidence either is superior
• 20% of all thromboembolic e...
Thrombosis rates
• Embolism or valve thrombosis with mechanical
valve replacements
• No anticoagulation
• Aortic valve 4-1...
Questions?
Stopping anti-platelet agents
• Routine CABG stop anti-platelet drug 7 days pre-op
• NSTEMI/MI/Prior to PCI
• Clear benefi...
Stopping Warfarin pre-op
• Low risk of thrombosis
• Bileaflet mechanical AVR with no other risk factors
• Stop warfarin 3-...
What about newer oral antithrombotics?
• Direct thrombin inhibitor – Dabigatrin
• RE-ALIGN study
• vs warfarin in mechanic...
BCC4: Sarah Wesley- To Thin or Not To Thin (The heart and anticoagulation)
Upcoming SlideShare
Loading in...5
×

BCC4: Sarah Wesley- To Thin or Not To Thin (The heart and anticoagulation)

918

Published on

To thin or not to thin? That is a great question which Wesley helps answer with her talk on the heart and anticoagulation. This podcast was recorded at BCC4. Full posts can be found at intensivecarenetwork.com

Published in: Health & Medicine, Technology
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
918
On Slideshare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
7
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Transcript of "BCC4: Sarah Wesley- To Thin or Not To Thin (The heart and anticoagulation)"

  1. 1. To thin or not to thin? Dr Sarah Wesley Cairns 2013
  2. 2. 64yo CABG x3 • On pump, LIMA to LAD and SVG to OM1 and Cx • PMHx: hypertension and hypercholesterolaemia • What antiplatelet therapy and when? Aspirin Aspirin + Clopidogrel Warfarin
  3. 3. 64yo CABG x3 • Aspirin at 6h if bleeding not an issue and daily afterwards • 75-150mg optimal dose • Reduction in mortality/CVA/MI/AKI Aspirin Aspirin + Clopidogrel Warfarin
  4. 4. 64yo CABG x3 • Are there any indications for dual (aspirin and clopidogrel) antiplatelet therapy?
  5. 5. 64yo CABG x3 • Dual therapy • CABG post acute coronary syndrome • Stent in situ not bypassed by graft • Off-pump CABG • Not indicated specifically for SVG • SVG 15% occlude in 1 year and 50% in 10 years • CASCADE study 2008 • Clopidogrel and aspirin in SVG • Showed no benefit in addition of clopidogrel
  6. 6. 64yo CABG x3 • Clopidogrel acceptable alternative if allergic to aspirin • No data showing superior • Aspirin remains drug of choice in routine on-pump CABG
  7. 7. 64yo CABG x3 • He goes on to develop AF day 2 • 3 days later remains in rate controlled AF on amiodarone • Would you start any additional anticoagulation? Clopidogrel iv Heparin + Warfarin None
  8. 8. 64yo CABG x3 • iv heparin and warfarin if remains in AF for > 48h • Aim INR 2-3 • Double the risk of stroke with no anticoagulation • If reverts to sinus within 48h • Evidence equivocal for aspirin alone or adding warfarin Clopidogrel iv Heparin + Warfarin None
  9. 9. Questions ?
  10. 10. 72yo tissue AVR • EF 45% with moderate LVH • Sinus rhythm • No previous DVT/PE • No post-operative complications • What anticoagulation therapy should he have and when? Clopidogrel Aspirin Warfarin
  11. 11. 72yo tissue AVR • No risk factors for VTE disease -> aspirin alone • Stroke rate of 0.2% for AVR in sinus Clopidogrel Aspirin Warfarin
  12. 12. 72yo tissue AVR • Risk factors for VTE disease • AF, EF< 30-35%, hypercoagulable or previous VTE • Warfarin with INR 2-3 Clopidogrel Aspirin Warfarin
  13. 13. 54yo Mechanical AVR • What if he was 54 and his original operation was a mechanical AVR? • Normal coronary arteries • No risk factors for cardiovascular disease Clopidogrel + Aspirin Aspirin iv Heparin + Warfarin
  14. 14. 54yo Mechanical AVR • Warfarin and iv heparin • Iv heparin continues till INR therapeutic for 2 days • Intensity of warfarin relates to thrombogenicity of valve and risk factors for thrombus formation • INR 2.5 for low risk up to 3.5 for high risk • Risk relates to • Type of valve • Risk factors for VTE disease
  15. 15. Mechanical AVR • Warfarin alone or combination warfarin and anti- platelets? • Balance of thrombosis risk vs bleeding
  16. 16. Mechanical AVR • Add aspirin to warfarin if risk factors for cardiovascular disease, stents, previous PE, high risk valve • Many guidelines recommend adding aspirin unless concerns over bleeding • Significant reduction in thromboembolism and all cause mortality 9 -> 4/5% • Increase in bleeding risk 5 -> 8%
  17. 17. 63yo with mechanical MVR • Second generation valve inserted • Past history of Atrial Fibrillation • EF 40% • What anticoagulation therapy should she have and when?
  18. 18. MV repair or tissue MV • What if she’d had a mitral valve repair or tissue valve rather than mechanical valve replacement and was in sinus rhythm?
  19. 19. MV repair or tissue MV • 3 months warfarin or antiplatelets • No evidence either is superior • 20% of all thromboembolic events in first month
  20. 20. Thrombosis rates • Embolism or valve thrombosis with mechanical valve replacements • No anticoagulation • Aortic valve 4-12% per year • Mitral valve 10-22% per year • AVR with anticoagulation • Warfarin 1% per patient per year • Aspirin 2.2% per patient per year • MVR and AVR with risk factors for VTE • 2% and 4.5% respectively
  21. 21. Questions?
  22. 22. Stopping anti-platelet agents • Routine CABG stop anti-platelet drug 7 days pre-op • NSTEMI/MI/Prior to PCI • Clear benefits for clopidogrel and aspirin administration shown in many large RCT • Guidelines recommend stopping clopidogrel 5-7 days before surgery if clinical condition allows • 1% increase in risk of MI during this time
  23. 23. Stopping Warfarin pre-op • Low risk of thrombosis • Bileaflet mechanical AVR with no other risk factors • Stop warfarin 3-5 days pre-op no heparin required • High risk of thrombosis • Mechanical MVR/Mechanical AVR with risk factors • Stop warfarin and start heparin when INR < 2 • Restart heparin as early after surgery as as bleeding allows
  24. 24. What about newer oral antithrombotics? • Direct thrombin inhibitor – Dabigatrin • RE-ALIGN study • vs warfarin in mechanical valves • Stopped early as increased risk of CVA/MI/Thrombosis • Factor Xa inhibitor - Rivaroxaban • Not studied and not recommended
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×